Bio-Works Technologies AB (BIOWKS) — Cash Flow-to-Debt Ratio
Bio-Works Technologies AB (BIOWKS) has a Cash Flow-to-Debt Ratio of -0.19x as of December 2025, meaning its operating cash flow of Skr-4.17 Million could theoretically repay 0% of its total liabilities (Skr21.55 Million) in one year. See Bio-Works Technologies AB (BIOWKS) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Bio-Works Technologies AB Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Bio-Works Technologies AB across 11 annual periods. Also explore Bio-Works Technologies AB (BIOWKS) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Bio-Works Technologies AB (2015–2025)
Year-by-year debt coverage analysis for Bio-Works Technologies AB. For market capitalisation and broader financial context, see BIOWKS market cap.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.87x | Skr-18.81 Million | Skr21.55 Million | ▲ +84.0% |
| 2024 | -5.46x | Skr-43.17 Million | Skr7.91 Million | ▼ -67.6% |
| 2023 | -3.26x | Skr-58.99 Million | Skr18.12 Million | ▼ -95.3% |
| 2022 | -1.67x | Skr-39.88 Million | Skr23.92 Million | ▼ -54.0% |
| 2021 | -1.08x | Skr-13.37 Million | Skr12.35 Million | ▲ +79.9% |
| 2020 | -5.39x | Skr-43.36 Million | Skr8.04 Million | ▲ +20.7% |
| 2019 | -6.79x | Skr-40.04 Million | Skr5.89 Million | ▼ -12.9% |
| 2018 | -6.02x | Skr-34.69 Million | Skr5.76 Million | ▼ -69.8% |
| 2017 | -3.55x | Skr-21.23 Million | Skr5.99 Million | ▼ -8.8% |
| 2016 | -3.26x | Skr-14.46 Million | Skr4.44 Million | ▲ +42.9% |
| 2015 | -5.70x | Skr-13.12 Million | Skr2.30 Million | — |